Germany Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany mammography market was valued at USD 98.33 million in 2021 and is projected to register a CAGR of 8.86% during the forecast period (2022-2027).

The COVID pandemic had an adverse effect on market growth. Germany stopped all elective studies and treatments aimed at patients with advanced tumors as a result of COVID-19. In addition, a research letter from 2021 titled "Documented New Cases of Cancer in the Clinical Cancer Registries of the German State of Saxony during the COVID-19 Pandemic" noted that an evaluation of the anticipated and actual reports of new cancer cases revealed a notable decline during the lockdown period that began in March 2020. According to the study, there were almost 9% fewer incidences of breast cancer reported. Fewer doctor visits, a decline in statutory health insurance-funded services, fewer diagnostic referrals as examinations were delayed, and a reduction in the scope of skin cancer, colonoscopy, and mammography screenings provided after the nationwide lockdown were some of the causes of this decline in the documentation. Although there was a backlog of roughly a year's worth of mammography procedures, breast cancer screening techniques resumed to a greater extent in 2021, with clinics, diagnostic centers, and mobile units operating across the nation. The country experienced a number of difficulties with breast screening as a result of the aforementioned issues, but it is anticipated that the market will rebound.

Factors such as the technological advancements in breast imaging, and the investment from various organizations in breast cancer screening campaigns are driving the market. In Germany, the incidence of breast cancer is rising significantly. In Germany, the five-year prevalence of breast cancer was 299,702 in 2020, according to data from the International Agency for Research on Cancer. As a result, the nation's high breast cancer prevalence is anticipated to raise the demand for mammography, prompting individuals to visit clinics for screening. The market is anticipated to grow as a result. Initiatives by key market players are another factor in market growth. In January 2021, SOMATEX Medical Technology GmbH, a pioneer in biopsy site markers and localization technologies, was purchased by Hologic Inc. E-Med Solutions GmbH, Berlin, a consortium of investors led by the German private equity firm Westlake Partners, previously owned the business. Similarly, in January 2021, GE Healthcare ordered mobile mammography equipment from Toutenkamion Group for one of its clients, a private radiology clinic in Germany. Thus, the abovementioned factors are expected to increase the market growth.

However, the risk of adverse effects from radiation exposure, and reduction in reimbursement are expected to hinder the market growth.

Key Market TrendsDiagnostic Centers Segment is Expected to Hold a Significant Market Share Over the Forecast Period

The presence of a large number of diagnostic centers in the country, the increasing prevalence of breast cancer, and the presence of good healthcare infrastructure are the major factors attributing to the growth of this segment. The increasing strategic initiatives by the major players are also expected to boost the market growth. In Germany, the prevalence of breast cancer is rising gradually. In Germany, there were approximately 69,697 new instances of breast cancer reported in 2020, along with 20,579 fatalities, according to data from the International Agency for Research on Cancer. Numerous businesses run numerous programs to assist with breast cancer screenings. For instance, in and around Paderborn, Germany, Radiologie am Theater has three special breast cancer diagnostic facilities. According to the center's website, more than 15,000 breast exams are performed there annually. Two-thirds of these are screenings, which use traditional 2D mammography, while the remaining third are diagnostic mammographies, which include digital breast tomosynthesis to some extent. Such diagnostic facilities should accelerate market expansion. Mammovista B.smart, the software from Siemens Healthineers, was released in March 2021. The entire reading workflow for breast imaging can be sped up using the Mammovista B.smart software solution. The program enables transparency of key processes in the mammography examination process while finding potential bottlenecks. Such corporate releases are likely to increase the comfort of diagnostic facilities with large mammography images. This should accelerate market expansion.

Hence, the above developments are further expected to improve the market growth in this segment.

Competitive Landscape

Germany mammography market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Canon Inc. (Canon Medical Systems Corporation), GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.